Cannabis Sector Tumbles as Organigram Hits $1.11 in Broad Selloff

Cannabis equities experienced another volatile trading session Wednesday as sector-wide selling pressure drove most major names lower. Organigram Holdings (OGI) led the decline, falling to $1.11 per share as investors continued rotating away from cannabis positions amid broader market uncertainty.

The selloff reflects persistent challenges facing cannabis operators as they navigate a complex regulatory environment and intensifying competition. Multi-state operators and Canadian licensed producers alike face margin compression from oversupply in key markets, while federal banking restrictions continue limiting access to traditional financing channels.

Organigram's decline to the $1.11 level represents a critical technical threshold for the New Brunswick-based cultivator, which has struggled to maintain momentum following mixed quarterly results. The company's valuation compression mirrors broader sector trends as institutional investors remain cautious on cannabis fundamentals despite ongoing state-level legalization efforts.

The weakness comes as cannabis companies prepare for another challenging earnings season, with analysts expecting continued pressure on gross margins and cash flow generation. Rising interest rates have particularly impacted growth-oriented cannabis names, as investors demand clearer paths to profitability rather than pure revenue expansion.

Sector dynamics remain fluid as operators focus on operational efficiency and market consolidation opportunities. While state-level cannabis sales continue growing, public market valuations suggest investors expect significant restructuring before the next sustained rally materializes.